AngioInsight Appoints Scott Burger as CEO

AngioInsight, a medical imaging technology company, has appointed Scott Burger as its new chief executive officer (CEO).

Burger touts more than two decades of leadership experience in the healthcare and medical technology sectors. He previously held senior executive roles at healthcare companies including Elucid, CorVista Health, HeartFlow, and Johnson & Johnson.

AngioInsight believes Burger’s strategic vision and deep understanding of the healthcare landscape align perfectly with its mission to revolutionize diagnosing cardiovascular and microvascular disease in the cath lab.

“I am honored and excited to lead AngioInsight at such a pivotal moment,” said Scott Burger. “The potential of AngioInsight’s technology to impact patient care is tremendous, and I look forward to working closely with our talented team to advance our mission of improving diagnostic accuracy and patient outcomes.”

Under Burger’s leadership, AngioInsight said it plans to accelerate its clinical and development efforts, and strengthen its market presence and adoption. The pivotal clinical study, INSIGHT|AI pivotal clinical study is scheduled to begin in the coming months led by Todd Villines, MD of University of Virginia.

“It is exciting to be working on the INSIGHT|AI clinical study in order to bring this important solution to enhance detection and management for cardiovascular and microvascular disease,” said Dr. Villines.

AngioInsight is a developer of an advanced AI solution aimed at transforming the way cardiovascular diseases are diagnosed and managed. The company’s proprietary platform provides clinicians with real-time insights for anatomical and functional assessment, as well as detection of microvascular disease often missed or misdiagnosed, especially in women.